Gilead Sciences GILD
NASDAQ GILD
$168.08 +0.13 (+0.08%)
At close: Nov 13, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Change in Accrued Expenses (2009 - 2026)

Updated

Gilead Sciences (GILD) posted Change in Accrued Expenses of $338 million for Q2 2026, compared with -$166 million a year earlier.

Analysis

Gilead Sciences (GILD) Change in Accrued Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accrued Expenses at Gilead Sciences was $52 million, up 10.6% year-over-year; for FY2025, it came in at $6 million, down 94.4% from FY2024.

  • Annual Change in Accrued Expenses shows a five-year compound annual growth rate of -60.7% (FY2020 to FY2025).
  • In prior years, Gilead Sciences' Change in Accrued Expenses was $108 million in FY2024 (-76.4%), $458 million in FY2023, -$775 million in FY2022 and $689 million in FY2021 (+7.7%).
  • Quarterly Change in Accrued Expenses has run from a low of -$1.66 billion in Q1 2022 to a high of $1.54 billion in Q4 2021 over five years.
  • The strongest year-over-year quarter for Change in Accrued Expenses in the past five years was Q3 2025, with growth of 433.6%; the weakest was Q4 2022, with a decline of 76.9%.
  • According to Business Quant data, Change in Accrued Expenses for the three prior quarters was -$702 million (Q1 2026), -$395 million (Q4 2025) and $811 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 983.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn -7.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 756.00 Mn
Jun 30, 2026 338.00 Mn
Mar 31, 2026 -702.00 Mn
Dec 31, 2025 -395.00 Mn
Sep 30, 2025 811.00 Mn
Jun 30, 2025 -166.00 Mn
Mar 31, 2025 -244.00 Mn
Dec 31, 2024 305.00 Mn
Sep 30, 2024 152.00 Mn
Jun 30, 2024 -174.00 Mn
Mar 31, 2024 -175.00 Mn
Dec 31, 2023 317.00 Mn
Sep 30, 2023 50.00 Mn
Jun 30, 2023 634.00 Mn
Mar 31, 2023 -543.00 Mn
Dec 31, 2022 356.00 Mn
Sep 30, 2022 164.00 Mn
Jun 30, 2022 362.00 Mn
Mar 31, 2022 -1.66 Bn
Dec 31, 2021 1.54 Bn
API Access

Gilead Sciences Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=GILD&period=max&api_key=YOUR_API_KEY